# Debate prop_0635__muse-wonder-1.0-high__deepseek-v4-pro-0813-high__s1__tpl_placement_active_20260813a

- topic_id: prop_0635
- proposition: AI model providers should face product-liability-style responsibility for foreseeable harms caused by deployed model behavior when reasonable safeguards were not implemented.
- model_pro: muse-wonder-1.0-high
- model_con: deepseek-v4-pro-0813-high
- side_swap: True

## Turn 1: PRO Opening

- model: muse-wonder-1.0-high
- raw_words: 319
- clipped_words: 319
- claim_ids: [P1.1], [P1.2], [P1.3], [P1.4], [P1.5]
- cited_claim_ids: (none)
- missing_claim_id_refs: (none)

[P1.1] When a company releases a product that predictably injures people, and it skipped precautions a careful manufacturer would take, the law does not let it shrug and blame the user. That rule should apply to AI providers.
[P1.2] Providers are the actors who can prevent these harms. They choose the training data, set system instructions, tune refusals, build filters, decide what evaluations to run, and choose whether to release broadly, stage the rollout, add warnings, or log dangerous use. A person harmed by a model — or a user handed its output — cannot inspect the weights, rewrite its guardrails, or patch the next million copies. Placing responsibility on the provider puts the cost on the least-cost preventer, not on the victim least able to avoid it.
[P1.3] This is not strict liability for every bad answer. The proposition has two limiting gates: the harm must be foreseeable, and reasonable safeguards must have been missing. Foreseeable means risks a provider should anticipate from testing and ordinary use: detailed instructions that materially enable wrongdoing, fabricated defamatory claims presented confidently as fact, unsafe medical or self-harm responses, or a screening model predictably screening out a protected group. Reasonable safeguards are the familiar toolkit: pre-release evaluation and red-teaming, filters proportionate to risk, clear limits and disclosures, refusal and safe-completion behavior, monitoring, and fixing known failures after reports.
[P1.4] If a provider did that work and a determined user still circumvented it, this standard does not punish them.
[P1.5] Without that backstop, the incentives point the wrong way. Safeguards cost money and slow launches, while the injuries fall on employers, patients, readers, and bystanders who never signed the terms of service. Liability makes safety a balance-sheet item: test before you ship, document what you found, insure against residual risk, and do not profit from a release you knew was under-guarded. Product liability made cars and machinery safer without banning them; it can do the same for AI.

## Turn 2: CON Opening

- model: deepseek-v4-pro-0813-high
- raw_words: 323
- clipped_words: 323
- claim_ids: [C1.1], [C1.2], [C1.3], [C1.4], [C1.5], [C1.6], [C1.7]
- cited_claim_ids: (none)
- missing_claim_id_refs: (none)

[C1.1] The product-liability frame breaks at its first step. A toaster, tire, or chainsaw has a defined function and bounded failure modes. A general-purpose model has no single use: the same system that drafts an email can be prompted for malware, medical advice, defamation, or self-harm scripts. Foreseeability does not narrow that.
[C1.2] Generative systems are combinatorial and adversarial; providers can anticipate categories of misuse but cannot know which of millions of prompts will produce harm. After the fact, every harm looks foreseeable; before release, no finite red-team can prove the system safe. The proposal becomes liability by hindsight.
[C1.3] The “reasonable safeguards” gate has the same problem. If reasonable means whatever a later expert says could have been added—another filter, refusal rule, or output classifier—then a provider can always be faulted. No model refuses everything; a 99.9 percent block rate still leaves failures. A standard that demands near-perfect prevention is not a limiting gate; it is strict liability with extra litigation.
[C1.4] The incentive claim is also backwards. In ordinary products, the manufacturer controls the design and the user merely operates it. In deployed AI, the downstream deployer chooses the domain, data, system prompt, audience, and whether a human is in the loop. A bank denying credit, a clinic triaging patients, or an employer screening resumes is better placed to test for bias, monitor outcomes, and intervene.
[C1.5] The proposition lets those deployers point upstream and escape the choices they actually made.
[C1.6] That distortion is not free. It penalizes open-weight and general-purpose releases because the provider cannot control thousands of downstream adaptations. Faced with unbounded downstream liability, providers will restrict access, lock down useful tools, or avoid high-risk sectors—not because a design is unsafe, but because residual misuse is treated as manufacturer fault.
[C1.7] The product-liability analogy is not just imperfect: it puts liability on the party least able to observe actual use, while the party best placed to prevent the concrete harm gets an escape. Reject it.

## Turn 3: PRO Rebuttal 1

- model: muse-wonder-1.0-high
- raw_words: 326
- clipped_words: 326
- claim_ids: [P2.1], [P2.2], [P2.3], [P2.4], [P2.5], [P2.6], [P2.7]
- cited_claim_ids: (none)
- missing_claim_id_refs: (none)

[P2.1] My opponent turns 'foreseeable' into 'predict every prompt' and 'reasonable' into 'perfect.' Neither is in the motion. A carmaker need not foresee the exact crash to know brakes must be tested; a chemical maker need not foresee the exact misuse to warn and formulate safely. For AI, foreseeability operates at the level of risk categories providers already test for: uplift for wrongdoing, discriminatory screening, unsafe medical advice, defamatory fabrication.
[P2.2] If red-teaming, internal evals, or user reports surface that category, it is foreseeable. If a novel prompt produces a truly novel harm despite proportionate testing, the gate protects the provider.
[P2.3] The same answer defeats the strict-liability charge. A residual failure is not proof a safeguard was unreasonable to omit. The question is process and proportionality before release: did the provider evaluate the known risk, implement filters or refusals that work at a reasonable rate, disclose limits, monitor, and patch known holes? A provider with a strong block rate and documented follow-through has a defense precisely because perfection is not required.
[P2.4] What my opponent calls hindsight is often just evidence — a skipped eval, an ignored warning, a known jailbreak shipped anyway.
[P2.5] Their best point, downstream control, proves shared responsibility, not provider immunity. Yes, a bank or clinic chooses the domain and must answer for its deployment. Nothing in this proposition gives it an escape; product regimes routinely hold multiple actors responsible for different failures. But the deployer cannot retrain the base model, inspect its training failures, or fix a refusal system that collapses under ordinary phrasing.
[P2.6] Only the provider can do that work once for millions of uses. Making the provider answerable for its layer does not absolve the deployer for theirs.
[P2.7] Finally, open weights are a release choice, not an exemption. Staged release, capability documentation, use restrictions, and warnings scaled to risk are safeguards, not bans. If a provider chooses irreversible distribution of a powerful system, it should make that choice carefully — not externalize it.

## Turn 4: CON Rebuttal 1

- model: deepseek-v4-pro-0813-high
- raw_words: 282
- clipped_words: 282
- claim_ids: [C2.1], [C2.2], [C2.3], [C2.4], [C2.5], [C2.6], [C2.7]
- cited_claim_ids: [P2.1], [P2.3]
- missing_claim_id_refs: (none)

[C2.1] PRO’s rebuttal quietly rewrites the motion into a negligence-style process standard. But the proposition says product-liability-style responsibility—and that frame still collapses.
[C2.2] The category move in [P2.1] makes the limiting gate weaker, not stronger. If “uplift for wrongdoing,” “unsafe medical advice,” and “defamatory fabrication” count as foreseeable, they are always foreseeable for any general model. A provider cannot remove those categories without removing the fluent generation users want, because the same capability produces both.
[C2.3] The real question after an injury is never whether a risk category was known; it is whether some further filter, refusal, or warning could have stopped that particular output. That is liability by hindsight—a 99.9 percent block rate still fails the foreseeable-category test.
[C2.4] PRO says in [P2.3] that a residual failure is not proof a safeguard was unreasonable to omit. But juries will see a victim and a harmful output, not the pre-release process. Experts will always be able to name one more safeguard. The result is not a safe harbor; it is expensive, risk-averse refusal behavior dressed up as due care.
[C2.5] The deeper defect remains. Product liability asks whether the product is defective. A model that produces a harmful answer when prompted is doing its intended job, not malfunctioning like brakes that fail. The harm comes from the requested content, not from a broken function.
[C2.6] Downstream control is not merely shared; it is where concrete risk is managed. Banks, clinics, and employers choose the use, data, and human review.
[C2.7] Finally, “release choice” does not create control. Once weights are public, no provider can patch, monitor, or revoke downstream copies; fine-tuning strips refusals. The only reliable safeguard is not releasing. That is de facto strict liability for open models.

## Turn 5: PRO Pressure Questions

- model: muse-wonder-1.0-high
- raw_words: 68
- clipped_words: 68
- claim_ids: [P3.1], [P3.2]
- cited_claim_ids: (none)
- missing_claim_id_refs: (none)

[P3.1] Q1: If a provider's own red-teaming finds a jailbreak that reliably elicits instructions facilitating wrongdoing, and it ships without patching or warning, which other actor could have prevented that provider-level failure, and why should the provider bear no responsibility?
[P3.2] Q2: If deployers cannot inspect training data, weights, or refusal failures, how are they supposedly better placed than providers to prevent base-model harms like discriminatory screening or defamatory fabrication?

## Turn 6: CON Pressure Questions

- model: deepseek-v4-pro-0813-high
- raw_words: 64
- clipped_words: 64
- claim_ids: [C3.1], [C3.2]
- cited_claim_ids: (none)
- missing_claim_id_refs: (none)

[C3.1] Q1: You concede perfection is not required; name the concrete pre-release benchmark—block rate, eval coverage, or disclosure set—that gives a provider a safe harbor before trial rather than just a hindsight argument afterward.
[C3.2] Q2: If open weights cannot be patched, monitored, or revoked after release, and fine-tuning strips refusals, then is not releasing the model the only safeguard that reliably avoids that downstream liability?

## Turn 7: PRO Rebuttal 2

- model: muse-wonder-1.0-high
- raw_words: 327
- clipped_words: 327
- claim_ids: [P4.1], [P4.2], [P4.3], [P4.4], [P4.5]
- cited_claim_ids: (none)
- missing_claim_id_refs: (none)

[P4.1] A1: A provider gets a safe harbor by meeting a pre-release, risk-tiered checklist, not a magic number: evaluate the capability classes its model actually enables, test reproducible prompts from red-teaming and standard suites, patch or block high-severity failures recurring under ordinary use, apply refusals or safe completions proportionate to severity, disclose known limits, and monitor and patch after release. If that record shows the particular failure was residual despite those steps, reasonable safeguards were implemented. That guides engineering before trial; one universal block rate would be brittle across risks with very different severity.
[P4.2] A2: No. For open weights, reasonable safeguards scale to irreversibility: staged or gated release, pre-release capability evaluation, releasing a smaller or less dangerous checkpoint, clear capability and misuse documentation, and access controls where feasible. Only when evaluation shows severe, unmitigable uplift does delaying or withholding that tier become the reasonable step—just as some products are too dangerous to sell unguarded. Lower-risk open models remain releasable, so this is proportionality, not a ban.
[P4.3] Those answers defeat CON's central move. CON treats foreseeability as if it alone creates liability, but the motion requires both foreseeability and a missing reasonable safeguard. A known category with documented testing, effective mitigation, disclosure, and repair is a defense, not a conviction. Exposure arises from shipping a reproducible failure, ignoring reports, or relying on a deployer who cannot see or fix the base model.
[P4.4] Nor does “working as designed” end the inquiry. A design can function smoothly and still be unreasonably dangerous if it lacks a feasible guard, warning, or limit. The jury-hindsight worry applies to cars, drugs, and machinery too; courts manage it with state-of-the-art evidence and expert comparison, not by granting immunity.
[P4.5] So the comparison is clear: CON protects the one actor who can test and fix risks at scale even after its own warnings, while PRO imposes liability only when that actor skipped proportionate work. That is not perfection or a ban; it is accountability matched to control.

## Turn 8: CON Rebuttal 2

- model: deepseek-v4-pro-0813-high
- raw_words: 291
- clipped_words: 291
- claim_ids: [C4.1], [C4.2], [C4.3], [C4.4], [C4.5], [C4.6]
- cited_claim_ids: (none)
- missing_claim_id_refs: (none)

[C4.1] A1: No other actor is better placed to fix a jailbreak the provider itself found. But that supports ordinary negligence, failure-to-warn, or recall liability for a known, unpatched defect—not product-liability-style responsibility. The law already reaches that egregious case without treating generated text as a defective product. The product-liability rule goes much further: after any harmful output, a plaintiff can point to one more benchmark, filter, or refusal, so the provider is always said to have “failed” a safeguard.
[C4.2] That is hindsight, not a limiting condition.
[C4.3] A2: Deployers are not better placed by inspecting weights; they are better placed by controlling the concrete use. When a clinic uses a model to screen patients, the deployer chooses the cutoff, the data, and whether a clinician reviews the output. A provider cannot pre-test the infinite downstream prompts that turn a general model into a discriminatory screener or defamatory generator. If the provider left a known refusal failure unpatched, A1’s warning/recall solution applies.
[C4.4] But that does not make the base model design defective every time a deployer’s chosen use produces harm.
[C4.5] These answers expose the proposal’s structure. PRO keeps selecting cases where the provider obviously omitted a known fix and then uses those cases to defend a general product-liability standard. But the standard would not be limited to those cases: foreseeable categories are always present, and no realistic pre-release process covers every prompt. Providers facing that liability will restrict outputs, over-refuse, and stop open release—not because a model is unsafe, but because residual misuse is treated as a design defect.
[C4.6] The better rule is negligence, disclosure, and recall. Punish the unpatched jailbreak; do not turn general-purpose models into defective products whenever a downstream user asks for harm. That is why the proposition should be rejected.

## Turn 9: PRO Closing

- model: muse-wonder-1.0-high
- raw_words: 196
- clipped_words: 196
- claim_ids: [P5.1], [P5.2], [P5.3], [P5.4], [P5.5], [P5.6]
- cited_claim_ids: [C4.1]
- missing_claim_id_refs: (none)

[P5.1] The concession in [C4.1] settles it: no other actor is better placed to fix a jailbreak the provider itself found.
[P5.2] A deployer cannot patch the base model. A victim cannot inspect it. A user cannot make the next million copies safer. Only the provider decides whether a known, reproducible failure ships, gets mitigated, gets warned about, or gets fixed after reports.
[P5.3] Responsibility should follow that unique control.
[P5.4] Calling that duty ordinary negligence instead of product-liability-style responsibility changes the label, not the reason it exists — but the label matters because the dangerous choices are product choices: training, evaluation, refusal design, release scope, and post-release repair. Those choices are made once, upstream, for everyone downstream.
[P5.5] This standard still requires both a foreseeable risk and a missing reasonable safeguard. A residual failure after documented testing and proportionate mitigation is defended. What is not defended is shipping the known failure and pointing to the clinic, bank, or reader who never had the tools to stop it.
[P5.6] That is the one reason to affirm: without provider responsibility, the actor with exclusive power to prevent scale-wide harm can externalize it. With it, safety is built where safety can actually be built.

## Turn 10: CON Closing

- model: deepseek-v4-pro-0813-high
- raw_words: 196
- clipped_words: 196
- claim_ids: [C5.1], [C5.2], [C5.3], [C5.4]
- cited_claim_ids: (none)
- missing_claim_id_refs: (none)

[C5.1] PRO’s closing concedes the decisive point: its strongest cases are known, unpatched jailbreaks. That is negligence, failure to warn, or recall—not a defect in generated text. But the proposition does not stay there. Foreseeable categories like unsafe medical advice or defamatory fabrication are always present for any general model.
[C5.2] Once such a category exists, every harmful output becomes evidence that some further filter, refusal, or benchmark was omitted. A 99.9 percent block rate still fails. That is liability by hindsight with no workable safe harbor.
[C5.3] The deployer controls the concrete use: the clinic’s cutoff, the bank’s decision rule, the publisher’s editorial choices. The provider cannot pre-test infinite downstream prompts. Yes, only the provider can fix a known jailbreak—so apply negligence or recall to that specific failure. Do not treat every residual misuse as a product defect.
[C5.4] Weigh the incentives: under PRO’s rule, providers will refuse broad queries, curtail open release, and spend on litigation rather than safety, because the most defensible model is the one that rarely speaks. That does not stop harm; it shrinks the upstream actor who can actually build safety. CON’s rule punishes actual omission and leaves general-purpose models releasable. Reject the proposition.
